Intellectual Property Pulse

Rulemaking at the US Patent Office: Does Director Guidance On Discretionary Denials of Review Require Opportunity for Public Comment?

IP Tech Blog

MARCH 29, 2023

The case, brought by Apple Inc. and other technology companies together with Edwards Lifesciences, was remanded to the district court in the Northern District of California for further proceedings on this issue. and Apple Inc. Fintiv, Inc. Arthrex, Inc. Intri-Plex Techs.

Patent

Patent Litigation Designs Design

Rulemaking at the US Patent Office: Does Director Guidance On Discretionary Denials of Review Require Opportunity for Public Comment?

LexBlog IP

MARCH 29, 2023

Patent

Patent Designs Design Government

AIPPI UK Event Report: Roundup of 2022's Patent Cases

The IPKat

APRIL 5, 2023

In Neurim Pharmaceuticals (1991) Ltd and another company v Generics UK Ltd and another [2020] EWHC 3270 (Pat), Neurim was successful on all issues. After, at the form of order hearing, all costs went to them, but a few days later, the EPO revoked the patent.

Reporting

Reporting Patent Patent Infringement Technology

Rulemaking at the US Patent Office: Does Director Guidance On Discretionary Denials of Review Require Opportunity for Public Comment?

Rulemaking at the US Patent Office: Does Director Guidance On Discretionary Denials of Review Require Opportunity for Public Comment?

AIPPI UK Event Report: Roundup of 2022's Patent Cases

Stay Connected